SCIENCE BRIEFS.
Informing Ontario’s response to COVID-19
Science Brief Categories
- Epidemiology, Public Health & Implementation
- Health Equity & Social Determinants of Health
- Infectious Diseases & Clinical Care
- Public Policy & Economic Impact
Epidemiology, Public Health & Implementation
-
Update on COVID-19 Projections
-
Lessons Learned from Israel’s Reopening During a Nationwide COVID-19 Vaccination Campaign
-
Impact of Hospital Visitor Restrictions during the COVID-19 Pandemic
-
Update on COVID-19 Projections
-
Excess Mortality in Ontario During the COVID-19 Pandemic
Health Equity & Social Determinants of Health
-
COVID-19 Vaccination for People with Disabilities
-
A Vaccination Strategy for Ontario COVID-19 Hotspots and Essential Workers
-
Mobile In-Home COVID-19 Vaccination of Ontario Homebound Older Adults by Neighbourhood Risk
-
Mobile On-Site COVID-19 Vaccination of Naturally Occurring Retirement Communities by Neighbourhood Risk in Toronto
-
A Strategy for the Mass Distribution of COVID-19 Vaccines in Ontario Based on Age and Neighbourhood
Infectious Diseases & Clinical Care
-
Drugs and COVID-19: Information for Patients and Healthcare Professionals
-
Clinical Practice Guidelines Webinar: Medications for Outpatients with COVID-19
-
Ivermectin to Prevent Disseminated Strongyloides Infection in Patients with COVID-19
-
Risk of Vaccine-Induced Thrombotic Thrombocytopenia (VITT) following the AstraZeneca/COVISHIELD Adenovirus Vector COVID-19 Vaccines
-
Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) Following Adenovirus Vector COVID-19 Vaccination: Interim Guidance for Healthcare Professionals in the Outpatient Setting